Inogen reported $0 in Debt for its fiscal quarter ending in June of 2022.





Debt Change Date
Abbott USD 34.05B 20.19B Mar/2026
Accuray USD 170.24M 4.52M Sep/2024
AngioDynamics USD 6.3M 6.3M Feb/2025
Artivion USD 317.78M 619K Dec/2024
AtriCure USD 71.05M 736K Jun/2026
Baxter International USD 9.67B 20M Jun/2026
Becton, Dickinson and Co. USD 16.81B 471M Jun/2026
Boston Scientific USD 12.62B 1.6B Jun/2026
Cooper Companies USD 2.46B 39.5M Mar/2026
Dexcom USD 1.24B 154.7M Sep/2026
Edwards Lifesciences USD 598.8M 105.6M Sep/2026
Globus Medical USD 111.19M 4.03M Jun/2026
Inogen USD 0 0 Jun/2022
Insulet USD 962.1M 13.7M Sep/2026
Medtronic USD 28.15B 192M Jun/2026
Orthofix International USD 137.23M 338K Sep/2024
Philips EUR 8.14B 674M Sep/2026
ResMed USD 825.92M 17.25M Jun/2026
Steris USD 2.04B 42.7M Jun/2026
Stryker USD 14.18B 16M Sep/2026
Tandem Diabetes Care USD 603.39M 811K Sep/2026
Teleflex USD 2.87B 186.84M Jun/2026
X T L Biopharmaceuticals USD 269K 131K Dec/2025
Zimmer Biomet Holdings USD 7.5B 25.2M Sep/2026